Publications:155
Shuang Wang, PhD
About Me
Dr. Wang has a longstanding interest in liver biology and disease. Her major discoveries include an epigenetic crosstalk that controls mammalian liver regeneration (Wang et al. Dev Cell 2019) and an autocrine signaling circuit that emerges in hepatic stellate cells in advanced liver fibrosis (Wang et al. Sci Transl Med 2023). Her current NIH funded research program focuses on epigenetic mechanisms that regulate cell identity and memory in liver. For more info please visit wanglabnyc.com
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Liver Diseases
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS]
Education
BSc, University of Toronto
PhD, University of Toronto
PostDoc, Icahn School of Medicine at Mount Sinai
Publications
Selected Publications
- Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH. Kenneth Li, Vardhman Kumar, Tran To, Álvaro González-Domínguez, Janvi Huria, Maylene Yu, Bruno Cogliati, Chittampalli N. Yashaswini, Mark Miller, Andrea D. Branch, Bruno Giotti, Alexander M. Tsankov, Li Chen, Mathieu Petitjean, Jesse D. Kirkpatrick, Sangeeta N. Bhatia, Scott L. Friedman, Shuang Wang. Cell Reports
- Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis. Tran To, Shuang Wang. Journal of Visualized Experiments
- Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis. Chittampalli N. Yashaswini, Bruno Cogliati, Tianyue Qin, Tran To, Thomas Williamson, Tyler E. Papp, Kenneth Li, Raisa Rasul, Li Chen, Adi Lightstone, Haig Aghajanian, Hamideh Parhiz, Shuang Wang, Joel G. Rurik, Jonathan A. Epstein, Scott L. Friedman. Science Translational Medicine
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wang has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.